$AIP

Alpern Paul L sold $245K of AIP

Alpern Paul L (VP and General Counsel) sold 10,148 shares of Arteris, Inc. (AIP) at an average of $24.13 ($23.84–$24.64, $0.24M total) across 5 trades over 2026-10-01 to 2026-10-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Alpern Paul L
Published Oct 5, 2026, 8:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Bearish
medium confidence
Mentioned
$AIP
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPBearishLow
01

Why it matters

The disclosed sale is a standard 10b5‑1 execution, reflecting a pre‑planned liquidity event rather than a reaction to new company information.

02

Market read

The filing adds a modest data point for traders monitoring insider activity, but does not materially shift the stock's outlook.

03

What to watch

Potential upcoming corporate actions or market conditions that prompted the 10b5‑1 plan are not disclosed.

Relevance 3/10Novelty 3/10Timing: after market close

Background

Arteris, Inc. provides IP for interconnect solutions in the semiconductor industry. Insider transactions are monitored for signals of insider confidence.

Company-level read

Ticker impact

$AIPBearishMedium confidence
Context

VP and General Counsel Paul L. Alpern sold 10,148 shares for $244,831 via a 10b5‑1 plan, reducing his stake to 67,085 shares.

Expected impact

likely slight downward pressure as the market absorbs the disclosed sale

Evidence & confidence

Form 4 filings are primary disclosures; the transaction size is modest relative to typical market volume, suggesting limited but measurable impact.

Market effects

Minimal effect on the broader semiconductor IP sector.

Limited to U.S. investors tracking insider activity.

Low

Counterpoint

The sale may be routine and not indicative of future performance; investors could view the remaining large holding as a vote of confidence.

Key entities

  • Arteris, Inc.

    Provider of semiconductor interconnect IP, ticker AIP.

  • Paul L. Alpern

    Vice President and General Counsel of Arteris.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to